Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Basilea Pharmaceutica

Basilea Pharmaceutica

Basilea Pharmaceutica is a Basel-based company founded in 2000.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 8 Feb, 2024
"Infobox creation from: Wikidata data enrichment"
Golden AI profile picture
Golden AI
approved a suggestion from Golden's AI on 8 Feb, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Legal Entity Identifier
391200TTZP8EIPSJ5J200
"prospector:3699:3902229"
Amy Sar profile picture
Amy Sar
edited on 8 Feb, 2024
Edits made to:
Infobox (+2 properties)
Infobox
Industry
Biotechnology
Biotechnology
Location
Switzerland
Switzerland
Edits on 13 Dec, 2023
"NL fact extraction"
Golden Au profile picture
Golden Au
edited on 13 Dec, 2023
Edits made to:
Infobox (+3/-1 properties)
Infobox
Founded Date
January 1, 2000
B2X
B2B
B2B
0
Founded Date
2000
0
Number of Employees (Ranges)
51 – 2000
Edits on 24 May, 2023
"Clean up website values by canonicalizing and removing duplicates"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
http://www.basilea.com/
Edits on 7 Sep, 2022
"Funding autocalculation"
Golden AI profile picture
Golden AI
edited on 7 Sep, 2022
Edits made to:
Infobox (+4 properties)
Infobox
Latest Funding Round Date
September 7, 2022
Latest Funding Round Amount (USD)
76,010,000
Latest Funding Type
Initial public offering (IPO)
Initial public offering (IPO)
Total Funding Amount (USD)
76,010,000
"Found on funding round"
Golden AI profile picture
Golden AI
edited on 7 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Investors
Athyrium Capital Management, LP
Athyrium Capital Management, LP
Pavel Sorokin profile picture
Pavel Sorokin
edited on 7 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Funding Rounds
‌
Basilea Pharmaceutica - Post-IPO Debt, September 2022
Edits on 26 Jul, 2022
Patrick Pum profile picture
Patrick Pum
edited on 26 Jul, 2022
Edits made to:
Infobox (+5 properties)
Infobox
Board of Directors
‌
Domenico Scala (manager)
0
‌
Thomas Werner (entrepreneur)
0
CIK number
1,651,5950
Place of incorporation
Switzerland
Switzerland
0
SIC code
2,8340
Edits on 24 Jul, 2022
Artur Dunbar profile picture
Artur Dunbar
edited on 24 Jul, 2022
Edits made to:
Infobox (+10/-2 properties)
Infobox
Legal name
Basilea Pharmaceutica AG
Industry
Legal name
Basilea Pharmaceutica Ltd
Company Operating Status
Active
Contact page URL
https://www.basilea.com/contact
Crunchbase URL
https://www.crunchbase.com/organization/basilea-pharmaceutica-ltd
Email address
info@basilea.com0
Full address
Basilea Pharmaceutica International Ltd, Allschwil Hegenheimermattweg 167b 4123 Allschwil Switzerland0
Phone number
+416160611110
Pitchbook URL
https://pitchbook.com/profiles/company/55288-90
Exchange
SIX Group
SIX Group
0
Ticker symbol
BSLN0
Edits on 16 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 16 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Organization
Organization
Edits on 8 Apr, 2022
"Patent autocalculation"
Golden AI profile picture
Golden AI
edited on 8 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patents assigned (count)
54
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox (-12 properties)
Infobox
Patents
‌
US Patent 7115643 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
‌
US Patent 7151182 Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives
‌
US Patent 7189858 N-phenyl substituted carbamoyloxyalkyl-azolium derivatives
‌
US Patent 7262307 1′-benzyl-3-bromo-[1,3′]bipyrrolidinyl-2-one
‌
US Patent 7385061 Furazanobenzimidazoles
‌
US Patent 7423157 Substituted benzimidazoles and their use for inducing apoptosis
‌
US Patent 7459561 N-substituted carbamoyloxyalkyl-azolium derivatives
‌
US Patent 7511154 Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts
‌
US Patent 7524823 Macrolides
‌
US Patent 7531650 Cephalosporin salts in crystalline form
‌
US Patent 7816537 Process for the manufacture of epoxybutanol intermediates
‌
US Patent 7951957 Substituted benzimidazoles and their use for inducing apoptosis
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits on 6 Dec, 2021
Golden AI profile picture
Golden AI
edited on 6 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patents
‌
US Patent 7816537 Process for the manufacture of epoxybutanol intermediates
Edits on 2 Dec, 2021
Golden AI profile picture
Golden AI
edited on 2 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patents
‌
US Patent 7531650 Cephalosporin salts in crystalline form
Golden AI profile picture
Golden AI
edited on 2 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patents
‌
US Patent 7524823 Macrolides
Golden AI profile picture
Golden AI
edited on 2 Dec, 2021
Edits on 1 Dec, 2021
Golden AI profile picture
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patents
‌
US Patent 7459561 N-substituted carbamoyloxyalkyl-azolium derivatives
Golden AI profile picture
Golden AI
edited on 1 Dec, 2021
Edits on 30 Nov, 2021
Golden AI profile picture
Golden AI
edited on 30 Nov, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patents
‌
US Patent 7385061 Furazanobenzimidazoles

Find more companies like Basilea Pharmaceutica

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo